Coney, Joseph M. http://orcid.org/0000-0002-6889-2637
Zubricky, Ryan
Sinha, Samriddhi Buxy
Sonbolian, Nina
Zhou, Lujia
Hull, Thomas P.
Lewis, Shawn A.
Miller, David G.
Novak, Michael A.
Pendergast, Scott D.
Pham, Hang
Platt, Sean M.
Rao, Llewelyn J.
Schartman, Jerome P.
Singerman, Lawrence J.
Donkor, Richard
Fink, Margaret
McCoy, Jasmyne
Karcher, Helene
Article History
Received: 17 October 2022
Accepted: 22 January 2023
First Online: 1 February 2023
Declarations
:
: This study complied with the tenets of the Declaration of Helsinki. It is based on a medical records database built using medical records from nAMD patients who visited one of the 13 clinic sites and provided consent to have their deidentified data used for research purposes. All patient data was deidentified before being entered in the database and personal data was never shared. This study is based on a retrospective analysis of deidentified data obtained as part of routine clinical practice. As a result, no ethics approval was required.
: Not applicable.
: NS and HK are Novartis employees and HK is a Novartis shareholder. SBS was a Novartis employee at the time of this study and is a current employee of the Novartis Sandoz division. LZ is an employee of KMK Consulting, which was paid by Novartis to conduct the statistical analysis of the study. JMC has received grants from Alimera Sciences, Allergan/Abbvie, Apellis, Genentech, MacTel, National Eye Institute, Novartis, Regeneron and RegenexBio, consulting fees from Alimera Sciences, Apellis and RegenexBio, honoraria from Alimera Sciences, Allergan/Abbvie, Apellis, Genentech, Novartis, Regeneron and RegenexBio. DM reports consultancy fees and Speakers’ Bureau honoraria from Regeneron Pharmaceuticals. LS has received grants from Alkeus, Apellis, Genentech, Ionis Pharm, NGM, Biopharmaceuticals, Graybug Vision and Kodiak Sciences.